These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33675750)

  • 1. Rational affinity maturation of anti-amyloid antibodies with high conformational and sequence specificity.
    Desai AA; Smith MD; Zhang Y; Makowski EK; Gerson JE; Ionescu E; Starr CG; Zupancic JM; Moore SJ; Sutter AB; Ivanova MI; Murphy GG; Paulson HL; Tessier PM
    J Biol Chem; 2021; 296():100508. PubMed ID: 33675750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nature-inspired design and evolution of anti-amyloid antibodies.
    Julian MC; Rabia LA; Desai AA; Arsiwala A; Gerson JE; Paulson HL; Kane RS; Tessier PM
    J Biol Chem; 2019 May; 294(21):8438-8451. PubMed ID: 30918024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of recognition of amyloid-β (Aβ) monomer, oligomer, and fibril by homologous antibodies.
    Zhao J; Nussinov R; Ma B
    J Biol Chem; 2017 Nov; 292(44):18325-18343. PubMed ID: 28924036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based design of conformation- and sequence-specific antibodies against amyloid β.
    Perchiacca JM; Ladiwala AR; Bhattacharya M; Tessier PM
    Proc Natl Acad Sci U S A; 2012 Jan; 109(1):84-9. PubMed ID: 22171009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolating Anti-amyloid Antibodies from Yeast-Displayed Libraries.
    Desai AA; Zupancic JM; Smith MD; Tessier PM
    Methods Mol Biol; 2022; 2491():471-490. PubMed ID: 35482203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
    Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From monomer to fibril: Abeta-amyloid binding to Aducanumab antibody studied by molecular dynamics simulation.
    Frost CV; Zacharias M
    Proteins; 2020 Dec; 88(12):1592-1606. PubMed ID: 32666627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies against Aβ42 fibrils distinguish multiple aggregation state polymorphisms in vitro and in Alzheimer disease brain.
    Hatami A; Albay R; Monjazeb S; Milton S; Glabe C
    J Biol Chem; 2014 Nov; 289(46):32131-32143. PubMed ID: 25281743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural differences of amyloid-β fibrils revealed by antibodies from phage display.
    Droste P; Frenzel A; Steinwand M; Pelat T; Thullier P; Hust M; Lashuel H; Dübel S
    BMC Biotechnol; 2015 Jun; 15():57. PubMed ID: 26084577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An "epitomic" analysis of the specificity of conformation-dependent, anti-Aß amyloid monoclonal antibodies.
    Reyes-Ruiz JM; Nakajima R; Baghallab I; Goldschmidt L; Sosna J; Mai Ho PN; Kumosani T; Felgner PL; Glabe C
    J Biol Chem; 2021; 296():100168. PubMed ID: 33298522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformation-specific antibodies against multiple amyloid protofibril species from a single amyloid immunogen.
    Bonito-Oliva A; Schedin-Weiss S; Younesi SS; Tiiman A; Adura C; Paknejad N; Brendel M; Romin Y; Parchem RJ; Graff C; Vukojević V; Tjernberg LO; Terenius L; Winblad B; Sakmar TP; Graham WV
    J Cell Mol Med; 2019 Mar; 23(3):2103-2114. PubMed ID: 30663210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric isolation of drug-like conformational antibodies specific for amyloid fibrils.
    Desai AA; Zupancic JM; Trzeciakiewicz H; Gerson JE; DuBois KN; Skinner ME; Sharkey LM; McArthur N; Ferris SP; Bhatt NN; Makowski EK; Smith MD; Chen H; Huang J; Jerez C; Kane RS; Kanaan NM; Paulson HL; Tessier PM
    bioRxiv; 2023 Jul; ():. PubMed ID: 37461643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue.
    Canovi M; Markoutsa E; Lazar AN; Pampalakis G; Clemente C; Re F; Sesana S; Masserini M; Salmona M; Duyckaerts C; Flores O; Gobbi M; Antimisiaris SG
    Biomaterials; 2011 Aug; 32(23):5489-97. PubMed ID: 21529932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative flow cytometric selection of tau conformational nanobodies specific for pathological aggregates.
    Zupancic JM; Smith MD; Trzeciakiewicz H; Skinner ME; Ferris SP; Makowski EK; Lucas MJ; McArthur N; Kane RS; Paulson HL; Tessier PM
    Front Immunol; 2023; 14():1164080. PubMed ID: 37622125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-Engineering Therapeutic Anti-Aβ Monoclonal Antibody to Target Amyloid Light Chain.
    Bai J; Li X; Zhao J; Zong H; Yuan Y; Wang L; Zhang X; Ke Y; Han L; Xu J; Ma B; Zhang B; Zhu J
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β.
    Arndt JW; Qian F; Smith BA; Quan C; Kilambi KP; Bush MW; Walz T; Pepinsky RB; Bussière T; Hamann S; Cameron TO; Weinreb PH
    Sci Rep; 2018 Apr; 8(1):6412. PubMed ID: 29686315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformation-dependent scFv antibodies specifically recognize the oligomers assembled from various amyloids and show colocalization of amyloid fibrils with oligomers in patients with amyloidoses.
    Zhang X; Sun XX; Xue D; Liu DG; Hu XY; Zhao M; Yang SG; Yang Y; Xia YJ; Wang Y; Liu RT
    Biochim Biophys Acta; 2011 Dec; 1814(12):1703-12. PubMed ID: 21979582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid fibril recognition with the conformational B10 antibody fragment depends on electrostatic interactions.
    Haupt C; Morgado I; Kumar ST; Parthier C; Bereza M; Hortschansky P; Stubbs MT; Horn U; Fändrich M
    J Mol Biol; 2011 Jan; 405(2):341-8. PubMed ID: 21059358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
    Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
    Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG Conformer's Binding to Amyloidogenic Aggregates.
    Phay M; Welzel AT; Williams AD; McWilliams-Koeppen HP; Blinder V; O'Malley TT; Solomon A; Walsh DM; O'Nuallain B
    PLoS One; 2015; 10(9):e0137344. PubMed ID: 26367058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.